LANGHORNE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will be participating in The Microcap Conference, which will take place January 30th through February 1st at the Ceasars Atlantic City Hotel & Casino in Atlantic City, New Jersey.
Presentation Details:
Wednesday, January 31st, 10:25 – 10:45 AM and
Thursday, February 1st at 3:35 – 3:55 PM
Interested parties can register to attend here.
Management will be available for 1x1 meetings throughout the event. To schedule a 1x1 meeting, please contact your Microcap Conference representative or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it..
About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$2.65 |
Daily Change: | 0.03 1.15 |
Daily Volume: | 9,508 |
Market Cap: | US$17.990M |
May 13, 2025 November 13, 2024 November 11, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load